The Ovarian Cancer Opportunity: Overcoming Complexity in Global Studies
Each year in the US, more than 21,000 women will receive a new diagnosis of ovarian cancer according to the…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Trends in Renal Research: Nephrology’s Shift to Focus and Precision
Nephrology has long been a difficult space for drug development: trials were slow, complex, high cost, and often unrewarding, constrained…
-
Tell us: Is hospital connectivity keeping up with the demands of modern care in 2026?
For years, healthcare organizations have focused on enabling clinical mobility by giving clinicians access to systems, communication tools, and patient…
-
Operational Lessons from Global Nephrology Trials
From novel drug targets for chronic kidney disease (CKD)[i] to advances in multifunctional drugs promising better efficacy, recent developments in…
-
The future of quality in CDMOs: The five-stage journey to an advanced Pharmaceutical Quality System (PQS)
In the first part of our Q&A with Grace Breen, SVP, Quality, Sharp, we explored valuable insights derived from her…
-
Four ways to build a secure and scalable CGT distribution network
CGTs offer potentially life-changing treatment for a broad spectrum of complex diseases, from genetic conditions to cancers. The pace of…
-
Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers
Oncology drug development has shifted decisively towards precision immunotherapies, where biomarker-defined patient populations play a pivotal role. Immuno-oncology now represents…
-
Why Timelines Break Down in Rare Kidney Drug Development
Enrollment challenges continue to be a defining constraint in nephrology research. In a January 2026 snapshot of GlobalData’s clinical trial…
-
The hidden bottleneck in digital healthcare: Why hospital wireless networks are under pressure in 2026
Healthcare is entering a new era of digital transformation. In the US, competition among leading providers is driving rapid adoption…
-
CGT’s next obstacle: Securing the leukapheresis supply chain
Clinical trial numbers for CAR-T therapies have risen dramatically in recent years, and as these programmes expand beyond oncology into…